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Radiology, St Mary’s Hospital, London, UKBackground. Patients undergoing carotid endoluminal intervention are at risk of embolic stroke even with the use of distal
protection devices. Matrix metalloproteinases (MMPs) have been implicated as a causal factor in plaque instability leading
to spontaneous embolisation. We investigated whether plasma MMP levels correlated with the embolisation during carotid
endoluminal intervention.
Methods. Thirty circumferentially intact carotid endarterectomy specimens were subjected to a standardised angioplasty
procedure in a pulsatile ex vivo model. Emboli collected in a series of distal filters were counted and sized. Plasma samples
were collected pre-operatively and analysed for MMP-7 and MMP-8 levels using Western immunoblotting. MMP-1 and
MMP-13 levels were determined using ELISA. Emboli number and maximum size were correlated with plasma levels of the
MMPs using Spearmans rank.
Results. Total MMP-8 levels were related to maximum embolus size (rZ0.442, pZ0.005) but not emboli number (rZ
0.342, pZ0.052). MMP-1, -7 and -13 were not correlated with either emboli number or with maximum embolus size.
Conclusion. Pre-operative plasma MMP-8 levels are related to the size of emboli from plaques during carotid endovascular
intervention. Further in vivo studies need to be performed to assess the importance of this finding. There is potential for
development of plasma markers to identify those patients at greater risk of embolic stroke during carotid endoluminal
intervention.Keywords: Atherosclerosis; Emboli; Carotid angioplasty; Matrix metalloproteinase.Introduction
Carotid endovascular intervention has been pro-
posed as an alternative to surgical endarterectomy,
since an endoluminal approach may be safer in
high-risk patients and complications such as
haematoma formation and cranial nerve palsy
may be avoided. It may also permit day case
management1. However, even with the employ-
ment of distal protection devices, the risk of
embolic stroke remains a chief complication.2,3part to a meeting of the European Society of Vascular
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0500+ 08 $35.00/0 q 2004 Elsevier Ltd. All rights reserAlthough filter and balloon protection devices are
used, not all particles are captured by this
technique and there is a necessity to pass a guide
wire and device through a potentially unstable
atherosclerotic carotid plaque, which may dislodge
particulate matter. Previous work within our unit
has characterised emboli generated by endovascu-
lar intervention using an ex vivo model and studied
clinical and pharmacological factors that may
influence embolisation.4
MMPs are proteases that are capable of breaking
down all components of the extracellular membrane.
Increased MMP expression has been detected in
carotid plaques at the mRNA5 and protein level6,7
and has been associated with plaque instability.8
However, a direct link between MMP activity and
the number and size of emboli generated during
carotid endoluminal intervention is yet to be
established.Eur J Vasc Endovasc Surg 28, 500–507 (2004)
doi:10.1016/j.ejvs.2004.06.020, available online at http://www.sciencedirect.com onved.
MMPs and Embolisation 501Increased levels of MMPs have been detected in
unstable atherosclerotic lesions as well as peripherally
in the blood and have been proposed as a useful
marker of carotid and coronary plaque spontaneous
instability.9,10 The aim of this paper was to investigate
the relationship between the pre-intervention plasma
levels of collagenases (MMP-1, MMP-8 and MMP-13),
MMP-7 and embolisation during endovascular inter-
vention in a pulsatile, temperature controlled ex vivo
model to attempt to identify those at increased risk
of embolisation during carotid endovascular
intervention.MethodsPatients
Full Ethics Committee approval was obtained for this
study. Thirty patients who underwent carotid endar-
terectomy in a vascular surgical unit were consented
for inclusion in this study. Circumferentially intact
carotid endarterectomy specimens were collected
from patients at operation. These specimens under-
went a standardised angioplasty procedure in an ex
vivo pulsatile, temperature controlled angioplasty
model. Patient demographics and clinical details are
shown in Table 1. Such demographics are representa-
tive of a population of patients with high-grade
stenoses suitable for surgical intervention.Table 1. Demographics and clinical details of the 30 patients from wh
study in the ex vivo model
Demography
Female
Male
Mean age
Details of symptoms
Asymptomatic (for six months prior to surgery)
Recent symptoms (less than 1 month prior to surgery)
Symptoms (1–6 months prior to surgery)
TIA
CVA
Amaurosis fugax
Risk factors
Coronary disease
CABG
Smoking
Diabetes mellitis
Family history of vascular disease
Hypertension
Drug therapy
Established Statin therapy (O8 weeks)
Aspirin
Investigations
Mean ipsilateral ICA stenosis (%) on duplex
Abnormal CT scanEx vivo angioplasty
Preparation and angioplasty of carotid specimens was
carried out by a vascular trainee and one of two
radiologists with wide experience of endoluminal
procedures and tranining in carotid endoluminal
intervention. This procedure of carotid artery prep-
aration and angioplasty has been described pre-
viously4 and is discussed in brief.
A modified endarterectomy technique was used for
the removal of plaques as an intact cylinder without
incision into the core of the plaque or the lumen. The
specimens were then placed into an antibiotic laden
transport medium and stored at 4 8C. During our
series one soft plaque was not included in the study as
this was inadvertently damaged during
endarterectomy.
The specimen was invested into an expanded
polytetrafluoroethylene (PTFE) graft via a longitudinal
incision. The PTFE graft was wrapped around the
specimen without constriction of the lumen of the
plaque and was closed using a polypropylene suture.
The external carotid artery was suture ligated and was
not included within the graft. A silicone-based sealant
was applied to the suture line to minimise leakage.
A fluid with a similar viscosity to whole blood
consisting of 50% saline and 50% (v/v) glycerol was
passed through a continuous flow circuit as shown in
Fig. 1. The specimen and perfusate were warmed in
saline to 37 8C prior to the procedure. The specimen
was mounted within an angioplasty chamber andom the endarterectomised carotid specimens were obtained for the
8 (27%)
22 (73%)
68.8 yrs (range 51–79 yrs)
14 (47%)
9 (30%)
7 (23%)
9 (30%)
7 (23%)
7 (23%)
19 (63%)
7 (23%)
26 (87%)
6 (20%)
9 (30%)
23 (77%)
19 (63%)
23 (77%)
81.76% (range 62.5–97%)
20 (67%)
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Fig. 1. Diagrammatic representation of the ex vivo carotid
angioplasty model. The intact endarterectomised carotid
specimen was invested in a PTFE graft and placed in model
and subjected to conditions that mimic the normal physio-
logical state. Angioplasty was carried out through the
endovascular port. Three filters of different sizes were
placed distally to trap the emboli during the procedure.
C. D. Bicknell et al.502three stainless steel filters of different pore sizes (75,
200 and 1000 micron) were included into the circuit
distal to the plaque and were changed after each stage
of the procedure. The specimen was subjected to an
environment that mimics the normal flow patterns
within the internal carotid artery, with a peristaltic
pump that generated pulsatile flowwith a pulse rate of
60 cycles/min, a systolic pressure of 135 mmHg and a
flow rate of 156 ml/min through a 75–80% stenosis.
Initially, amorphous material and post-operative
clot that may have formed at the time of surgical
removal were flushed from the lumen. The vessel was
then perfused for 10 min during a control (pre-
intervention) period. In the second 10-min stage of
the procedure an initial angiogram was performed
and subsequently a 0.035 in. diameter guide wire was
passed through the lumen of the plaque. This was then
changed using a catheter to a 0.014 in. diameter wire,
which is compatible with the carotid angioplasty
balloons. During the final 10 min stage of the
procedure a 6 mm!4 cm angioplasty balloon (Boston
Scientific, UK) was positioned at the stenosis and was
inflated after 2 min to 12 kPa over 15 s and was then
deflated. Contrast imaging was performed after the
completion of balloon stage. Filters were changed after
each stage.
The emboli generated at each stage were trapped by
the filters downstream. The employment of filters of
different pore sizes is of clinical significance since a
1 mm pore size filter is consistent with the diameter of
the primary branches of the middle cerebral artery
(MCA)11 and the 200 micron pore size is similar to the
diameter of the perforating branches of the anterior
cerebral artery (ACA) and terminal cortical branches12
which have been shown to produce border zoneEur J Vasc Endovasc Surg Vol 28, November 2004infarcts when occluded. The smallest filter pore size
(75 micron) was chosen as this is similar to the pore
size encountered in some commonly used distal
protection devices. After the procedure each filter
was individually assessed by a single investigator
blinded to the stage from which the filter was
obtained. The number and the maximum size of the
emboli were recorded.Plasma samples
Lithium heparin blood samples were taken from
patients immediately prior to the operation via an
arterial line. The samples were then centrifuged at
1800g for six minutes at 20 8C. The plasma was
pipetted into multiple aliquots and frozen at K70 8C.
When required, the samples were placed into a water
bath at 37 8C and immediately stored on ice once
defrosted for the duration of each experiment.
Multiple aliquots of each sample was taken in order
to avoid freeze-thaw cycling.Determination of plasma total MMP-7 and MMP-8 levels:
Western immunoblotting
Detection of human MMP-7 and -8 protein was
performed by Western blot analysis. Plasma proteins
were separated out by their molecular weight using
12.5% SDS–PAGE gel. The gel was allowed to set
under water to allow a straight interface on top of
which a 5% stacking gel with wells was added for the
loading of the samples.
Initial titration assays determined the optimum
dilution for plasma samples. Fifteen microlitre of the
diluted sample was mixed with 5 ml of non-reducing
sample buffer (NRSB) consisting of 31.26% (v/v) 1 M
Tris–HCl (pH 6.8), 25% (v/v) glycerol, 10% (w/v)
Sodium Dodecyl Sulphate (SDS; Sigma, UK) and 0.1%
(w/v) bromophenol blue. Fifteen microlitre of this
mixture was then loaded onto the gel. The samples
were electrophoreised at a constant voltage of 140 V in
running buffer made of 3 g/l Trisma base (Sigma, UK),
14.42 g/l of Glycine (Sigma, UK) and 1 g/l SDS for 1 h.
After migration the plasma proteins were blotted
onto a 0.45 mmpore nitrocellulose membrane (Hybond
C, Amersham, UK) via electrophoresis in a Tris–
glycine buffer. Subsequently the nitrocellulose paper
was blocked by incubation in 5% casein/phosphate
buffered saline solution (PBS)/0.4% Tween 20 (Sigma,
UK) overnight at 2 8C in order to prevent non-specific
adsorption of the immunological reagents. A mouse
monoclonal anti-human MMP-7 or -8 antibody (Onco-
gene, USA) was used as the primary antibody. A
MMPs and Embolisation 503concentration of 0.1 mg/ml of the antibody (30 ml of
antibody in 12 ml 5% caesin/PBS) was added and
incubated for one hour for immunostaining. After
three washes with PBS solution the blot was further
incubated for an hour with a goat anti-mouse
horseradish peroxidase conjugated antibody followed
by a further three washes to wash off residual
antibody.
Enhanced chemiluminescent reagent (ECL; Amer-
sham UK) was added to visualise the reactive protein
bands and autoradiography was performed using
Kodak X-omat LS film (Kodak, UK) for a range of time
periods in order to optimise analysis of the protein
bands.
Images generated following autoradiography were
scanned and digitised using a Hewlett Packard ScanJet
Scanner (Hewlett Packard, UK) with the use of a
transparency adaptor. Subsequently analysis and
quantification of MMP-7 and -8 proteins was per-
formed using Scion Image Analysis Software (Scion
Cooperation, USA) and the quantity of MMP protein
present was expressed as a numerical value. In order
to account for gel-to-gel exposure differences, each
sample was normalised to a positive control reference
sample.Determination of plasma MMPs level: enzyme-linked
immunosorbent assays
Quantification of pro- and active level of the collagen-
ases was performed using commercial enzyme-linked
immunosorbent assays (ELISA; Biotrak, Amersham,
UK). Heparin stored samples were diluted to a 1 in 5
solution with assay buffer.
The same assay system was used for the quantifi-
cation of pro- and active forms for MMP-1 and MMP-
13 (Biotrak, Amersham, UK). For the MMP-1 assay
50 ml of anti-MMP-1 antibody was loaded into all the
wells of a microtitre plate which has been pre-coated
with F(ab’)2 goat anti-mouse antibody and was
incubated at 37 8C for 2 h. After incubation, 100 ml of
the working standards with a range of dilutions (0,
3.13, 6.25, 12.5, 25 and 50 ng/ml) and 100 ml of each of
the diluted samples were loaded in blind pairs. The
plate was then covered and incubated at 4 8C over-
night. All the wells are then aspirated four times with
wash buffer and 50 ml of 0.025 mM of p-aminophenyl-
mercuric acetate (APMA) solution was added into all
the wells to allow detection of total (pro- and active)
MMP-8 activity. Fifty microlitre of detection reagent,
consisting of equal volumes of detection enzyme (a
solution of modified urokinase in 50 mM Tris HCl
buffer pH 7.6 containing 1.5 mM sodium chloride,0.5 mM calcium chloride, 1 mM zinc chloride and
0.01% (v/v) BRIJ 35) and substrate (a solution of S-
2444 peptide substrate in 50 mM Tris–HCl buffer 7.6
containing 1.5 mM sodium chloride, 0.5 mM calcium
chloride, 1 mM zinc chloride and 0.01% (v/v) BRIJ 35),
was added to each well. The plate was then shaken for
20 s and the absorbance of the product was measured
immediately using a photospectrometer at 405 nm.
This reading was taken as the absorbance values at t0.
After 90 min of incubation at 37 8C a photospectronm-
etery reading taken as values at t1.5. The concentration
of all samples was determined from the standard
curve, which was derived from the readings obtained
from the working standards.
For the MMP-13 assay 50 ml of anti-MMP-13
antibody was loaded into all the wells of a microtitre
plate that has been pre-coated with F(ab’)2 goat anti-
mouse antibody and a range of standards were
prepared (0, 0.75, 1.5, 3, 6 and 12 ng/ml). The assay
was carried out as described above. The system was
incubated for three hours and the concentration of all
samples was determined from the standard curve,
which was derived from the readings obtained from
the working standards.
Both assay systems detect the pro and active
components of the MMP studied but not that bound
to the tissue inhibitors of metalloproteinases (TIMPs).Analysis
The total number of emboli and the maximum
embolus size generated during the three stages of the
ex vivo angioplasty procedure were correlated with the
pre-operative plasma total MMP-1, MMP-7, MMP-8
and MMP-13 levels.
In order to determine correlations, statistical ana-
lyses were carried out using non-parametric statistical
tests. Data were analysed using Spearman’s rank
correlation coefficient. Statistical significance was
assumed if the p value was less than 0.05 (p!0.05).ResultsPlasma total MMP-7 level and embolisation
Twenty-four samples were analysed by Western
blotting analysis. All samples contained MMP-7
protein with considerable variation in levels of
MMP-7 between samples. No correlation between
pre-operative plasma MMP-7 levels and emboli
numbers within the procedure (rZK0.152, pZ0.511)Eur J Vasc Endovasc Surg Vol 28, November 2004
C. D. Bicknell et al.504or emboli maximum size (rZK0.180, pZ0.435) was
demonstrated.Plasma total MMP-8 level and embolisation
Detection of total MMP-8 protein level was performed
by Western immunoblotting on 27 pre-operative
plasma samples. In all samples characteristic bands
could be seen following autoradiography containing
the MMP-8 protein at approximately the 75 kDa
position. These bands corresponded to MMP-8 bands
that are characteristic of a positive control (plasma
sample, kind gift of Mr G Thomas, Eastman Dental
Hospital, London). Definite differences in MMP-8
content could be demonstrated between plasma
samples.
A trend was demonstrated between the plasma
total MMP-8 levels and the total number of emboli
generated (rZ0.342, pZ0.052; Fig. 2(a)). There was a
significant correlation between the total plasma MMP-
8 level and the maximum emboli size (rZ0.442, pZ
0.005; Fig. 2(b)) observed during the ex vivo angio-
plasty procedure. There was no relationship between
plasma MMP-8 levels and any of the patient factors
detailed in Table 1.Plasma pro- and active MMP-1 level and embolisation
Pre-operative plasmaMMP-1 concentration was deter-
mined in 30 plasma samples by ELISA. The presence
of MMP-1 was demonstrated within the plasma
samples with variation in MMP-1 concentration.
There was no significant correlation between the
total number of emboli collected during the angio-
plasty procedure and the concentration of MMP-1 in
the plasma (rZ0.065, pZ0.278), nor was there a
statistical significant correlation between that and the
maximum embolus size (rZ0.151, pZ0.172).Plasma pro- and active MMP-13 level and embolisation
Levels of pro- and active forms of MMP-13 in 30 pre-
operative plasma samples were determined by ELISA.
The presence of MMP-13 was demonstrated within the
plasma samples with definite variation in MMP-13
concentration.
There was no statistical significant correlation
between the total MMP-13 concentration within the
plasma and the total emboli number generated during
the ex vivo angioplasty procedure (rZK0.01, pZ0.714)
or the maximum embolus size (rZK0.139, pZ0.638).Eur J Vasc Endovasc Surg Vol 28, November 2004Discussion
This study has demonstrated a relationship between
plasma levels of MMP-8 and embolisation during
carotid endoluminal intervention in an ex vivo model.
No significant correlation was observed between the
plasmaMMP-1, -7 and -13 concentrations and the total
emboli number or maximum embolus size.
Matrix metalloproteinases are important regulators
in the normal physiological processes such as wound
healing, growth, tissue morphogenesis and repair, cell
migration and angiogenesis. In addition, they have
been implicated in several inflammatory and patho-
logical processes such as atherosclerosis. The mature
plaque consists of a lipid core with an overlying
fibrous cap of a dense extracellular matrix (ECM)
consisting primarily of collagen, elastin and proteo-
glycan molecules. Disruption of this cap may expose
the lipid core leading to cholesterol embolisation and
may also uncover the highly thrombogenic material
beneath the cap, resulting in thrombus formation and
thromboembolisation.13,14 Although the precise mech-
anisms responsible for fibrous plaque rupture leading
to spontaneous embolisation are yet to be defined,
excessive degradation of the ECM scaffold mediated
by the MMPs has been postulated as one of the chief
causal factors.8
Since type I and III fibrillar collagen are regarded as
the major structural components contributing to the
integrity of the fibrous cap,15 the enzymes that are
capable of collagenlysis may be considered to be of
significant importance in plaque destabilisation and
rupture. Collagenases such as MMP-1 (interstitial
collagenase), MMP-8 (neutrophil collagenase), and
MMP-13 (collagenase 3) are the only enzymes capable
of cleaving the triple helix structure of collagen into
one- and three-quarter fragments16and have been
proven to be key players in the initial rate-limiting
step in collagen breakdown within plaques.17,18
Remnant fragments of collagen are then further
broken down into single a-chains and subsequently
become substrate for the gelatinases MMP-2 and
MMP-9, which have also been implicated as key
players in matrix re-modelling and subsequent embo-
lisation from plaques.19–22
Within the atherosclerotic plaque, expression of
MMP-1, -8 and -13 is apparent where in situ collagen
cleavage is evident within the plaque, especially
within the shoulder region. This has been identified
as a vulnerable site prone to rupture.17,18 The
degradation and weakening of the collagenous ECM
by these MMPs at these critical points could be
responsible for plaque instability. MMP-7 (matrilysin)
is also an important proteolytic enzyme again
  
Fig. 2. Total MMP-8 level determined byWestern immunoblotting in 28 pre-operative plasma samples plotted against (a) the
total number of emboli (rZ0.342, pZ0.052) and (b) maximum emboli size generated (rZ0.442; pZ0.005) during the ex vivo
angioplasty procedures.
MMPs and Embolisation 505involved in collagen breakdown. It has been demon-
strated in human atherosclerotic plaques at the
mRNA5 and protein level. Caesinolytic activity is
also increased in atherosclerotic plaques.23
Over 70% of an average stenosing atherosclerotic
plaque is composed of collagen-rich sclerotic fibrous
tissue that forms a cap overlying the soft lipid core ofthe plaque.24 The content of intact interstitial type I
collagen, being the chief load-bearing molecule, is
responsible for the stability of the fibrous cap.15
Although the collagenases have a similar substrate
specificity, MMP-8 has a higher affinity for type I
collagen in particular, in that it is three times more
efficient in its breakdown when compared to MMP-1Eur J Vasc Endovasc Surg Vol 28, November 2004
C. D. Bicknell et al.506and -13.17,25 Our study has established a relationship
between the total levels of MMP-8 in the plasma and
the total number of emboli as well as the maximum
embolus size generated during angioplasty in an ex
vivo model, which may suggest a role for MMP-8 in
promoting the progression of an atherosclerotic lesion
towards a vulnerable plaque that is more susceptible
to rupture.
We cannot be surewhether the presence of MMPs in
the plasma originates from the atherosclerotic carotid
plaque lesion. The findings in this studymay represent
one of three physiological phenomena. First of all, our
findings may signify a direct reflection of the MMP
content within the carotid plaque. Since previous
studies have identified over-expression of a range of
MMPs within the carotid plaques both at the protein
and mRNA level,5–7,23 there may be elevated MMP
release from the plaque directly into the circulation.
Equally the presence of MMPs detected in our study
may be indicative of an inflammatory condition from
the total body atherosclerotic burden. Thirdly it may
be a marker of end organ damage. Previous studies
suggest focal cerebral ischaemia influences plasma
levels of MMPs since an increased level of cerebral
MMPs in association with infiltrating leukocytes has
been shown in patients who died shortly after a
stroke.26
Previously, elevated levels of MMP-2 and -9 have
been found in patients with acute coronary syn-
dromes9 as well and in those with unstable angina27
and raised plasmaMMP-9 levels have been detected in
the blood of patients who have spontaneous plaque
instability as determined by TCD.10 In all of these
studies the source of raised plasma MMPs is not
entirely clear. In our study no patient experienced an
acute myocardial infarction or stroke within four
weeks prior to endarterectomy. Only one of our
patients had unstable angina within 4 weeks of
surgery. This would seem to suggest that end organ
damage is not the primary cause for raised plasma
levels of MMPs in those patients whose plaques
embolise significantly.
Although this procedure does not exactly represent
endoluminal therapeutic methods used in the carotid
artery, a standardised approach means that carotid
plaques may be compared. There are limitations to this
study as an ex vivo model cannot exactly replicate the
flow and velocity profiles of the carotid bifurcation.
We have attempted to create a pulsatile flow model
using pressure, flow, temperature, and viscosity
characteristics similar to that of the internal carotid
artery in man. We have chosen to invest the carotid
artery specimens devoid of adventitia into an
expanded PTFE graft as this material has previouslyEur J Vasc Endovasc Surg Vol 28, November 2004been shown to have similar elastic properties to that of
carotid artery adventitia.28 In addition, the technique
used to demonstrate embolisation during endovascu-
lar intervention is a fairly gross representation of the
stenting procedure that occurs in vivo. A 0.035 in.
guide wire was used in this study, which is less flexible
than a smaller diameter wire. This wire was chosen as
there was difficulty traversing the lumen of the plaque
with a 0.014 in. wire in initial trials, thought to be due
to the artificial shelf produced between the lumen of
the PTFE and carotid specimen. To standardize the
procedure we elected to use the 0.035 in. guide wire for
all plaques. Angioplasty was used in preference to
stenting in order to prevent embolisation being
masked by stent insertion and highlight differences
between plaques. Also stenting would have been more
difficult to standardise.
There may also be differences between the in vivo
situation and our ex vivo model due to plaque removal
and storage. We hope that careful removal of the
circumferentially intact plaque should not substan-
tially alter the morphology of the plaque. Storage of
the plaque may influence its stability, however, in our
study the number of days the plaque was stored prior
to angioplasty showed no correlation with number or
size of emboli produced and previous studies have
shown that most biochemical components of the
atherosclerotic plaque remain unchanged with storage
in saline at 4 8C.29
The limitations of the study described above may
mean that the size and number of emboli generated in
our study are not representative of those found in the
clinical situation. It must also be remembered that
emboli number and maximum size are a surrogate
measure for risk of neurological events. However,
because of the standardised nature of this study,
comparisons between plaques should be valid.
This study demonstrates an interesting relationship
between plasma MMP-8 levels and embolisation
during carotid intervention. Further in vivo investi-
gation needs to be undertaken to study the source of
these raised plasma collagenase levels and the role of
collagenases within the plaque with respect to
embolisation during intervention. It would be relevant
to investigate the MMP-8 content within the plaque
itself and relate that to the findings of this study.
Likewise, study of the other MMPs within the plaque
may give a clearer picture of their involvement in
breakdown of the fibrous cap and embolisation during
carotid stenting. This is important, as MMPs may
ultimately be a target for treatment to stabilise plaques
prior to endoluminal intervention. Although the
results we have shown in this study are very much
preliminary to the development of clinically
MMPs and Embolisation 507significant diagnostic aids, plasma MMP-8 levels may
have the potential to be useful blood markers that are
indicative of the embolic potential of carotid plaques.Acknowledgements
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